Swiss consumer goods giant Nestle has announced that it has bought a stake in American company Accera as it looks to expand its market into producing "brain health" products.
Accera is a privately held healthcare company in Broomfield and manufactures Axona, a milkshake that is prescribed to more than 30,000 Alzheimer's disease patients in the United States.
The investment was made by Nestle Health Science, a subsidiary of Nestle which is responsible for health products manufactured by the company.
Stating that the investment will prove to be a sound one for the company, Nestle Health Science SA's CEO and president Luis Cantarell said, "If you look from a financial point of view, this is a very small investment. If you look from a strategic point of view, which is why we created Nestle Health Science, this is a big hallmark towards promoting medical food as a source of an element to present and to help people manage chronic conditions like Alzheimer's."